Literature DB >> 11756671

Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response.

Robert A Mitchell1, Hong Liao, Jason Chesney, Gunter Fingerle-Rowson, John Baugh, John David, Richard Bucala.   

Abstract

The importance of the macrophage in innate immunity is underscored by its secretion of an array of powerful immunoregulatory and effector molecules. We report herein that macrophage migration inhibitory factor (MIF), a product of activated macrophages, sustains macrophage survival and function by suppressing activation-induced, p53-dependent apoptosis. Endotoxin administration to MIF(-/-) mice results in decreased macrophage viability, decreased proinflammatory function, and increased apoptosis when compared with wild-type controls. Moreover, inhibition of p53 in endotoxin-treated, MIF-deficient macrophages suppresses enhanced apoptosis and restores proinflammatory function. MIF inhibits p53 activity in macrophages via an autocrine regulatory pathway, resulting in a decrease in cellular p53 accumulation and subsequent function. Inhibition of p53 by MIF coincides with the induction of arachidonic acid metabolism and cyclooxygenase-2 (Cox-2) expression, which is required for MIF regulation of p53. MIF's effect on macrophage viability and survival provides a previously unrecognized mechanism to explain its critical proinflammatory action in conditions such as sepsis, and suggests new approaches for the modulation of innate immune responses.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11756671      PMCID: PMC117563          DOI: 10.1073/pnas.012511599

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

Review 1.  Phylogenetic perspectives in innate immunity.

Authors:  J A Hoffmann; F C Kafatos; C A Janeway; R A Ezekowitz
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

2.  Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration.

Authors:  H Nagahara; A M Vocero-Akbani; E L Snyder; A Ho; D G Latham; N A Lissy; M Becker-Hapak; S A Ezhevsky; S F Dowdy
Journal:  Nat Med       Date:  1998-12       Impact factor: 53.440

3.  Involvement of macrophage migration inhibitory factor (MIF) in the mechanism of tumor cell growth.

Authors:  N Takahashi; J Nishihira; Y Sato; M Kondo; H Ogawa; T Ohshima; Y Une; S Todo
Journal:  Mol Med       Date:  1998-11       Impact factor: 6.354

4.  Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF). Regulatory role in cell proliferation and glucocorticoid action.

Authors:  R A Mitchell; C N Metz; T Peng; R Bucala
Journal:  J Biol Chem       Date:  1999-06-18       Impact factor: 5.157

5.  Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids.

Authors:  M Leech; C Metz; P Hall; P Hutchinson; K Gianis; M Smith; H Weedon; S R Holdsworth; R Bucala; E F Morand
Journal:  Arthritis Rheum       Date:  1999-08

6.  Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of Gram-positive bacteria.

Authors:  T Calandra; L A Spiegel; C N Metz; R Bucala
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

7.  Cyclooxygenase-2: an essential regulator of NO-mediated apoptosis.

Authors:  A von Knethen; B Brüne
Journal:  FASEB J       Date:  1997-09       Impact factor: 5.191

8.  Etoposide and cisplatin induced apoptosis in activated RAW 264.7 macrophages is attenuated by cAMP-induced gene expression.

Authors:  A von Knethen; A Lotero; B Brüne
Journal:  Oncogene       Date:  1998-07-23       Impact factor: 9.867

9.  Inducible macrophage apoptosis following sepsis is mediated by cysteine protease activation and nitric oxide release.

Authors:  T E Williams; A Ayala; I H Chaudry
Journal:  J Surg Res       Date:  1997-07-01       Impact factor: 2.192

10.  Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis.

Authors:  M Bozza; A R Satoskar; G Lin; B Lu; A A Humbles; C Gerard; J R David
Journal:  J Exp Med       Date:  1999-01-18       Impact factor: 14.307

View more
  219 in total

1.  Macrophage migration inhibitory factor: a downregulator of early T cell-dependent IFN-gamma responses in Plasmodium chabaudi adami (556 KA)-infected mice.

Authors:  Diane Tshikudi Malu; Benoit Bélanger; François Desautels; Karine Kelendji; Esther Dalko; Jaime Sanchez-Dardon; Lin Leng; Richard Bucala; Abhay R Satoskar; Tatiana Scorza
Journal:  J Immunol       Date:  2011-04-25       Impact factor: 5.422

2.  Regulation of macrophage migration inhibitory factor expression by glucocorticoids in vivo.

Authors:  Gunter Fingerle-Rowson; Peter Koch; Rachel Bikoff; Xinchun Lin; Christine N Metz; Firdaus S Dhabhar; Andreas Meinhardt; Richard Bucala
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

Review 3.  D-dopachrome tautomerase (D-DT or MIF-2): doubling the MIF cytokine family.

Authors:  Melanie Merk; Robert A Mitchell; Stefan Endres; Richard Bucala
Journal:  Cytokine       Date:  2012-04-14       Impact factor: 3.861

Review 4.  Macrophage migration inhibitory factor (MIF): a promising biomarker.

Authors:  Gerrit Grieb; Melanie Merk; Jürgen Bernhagen; Richard Bucala
Journal:  Drug News Perspect       Date:  2010-05

5.  The MIF homologue D-dopachrome tautomerase promotes COX-2 expression through β-catenin-dependent and -independent mechanisms.

Authors:  Dan Xin; Beatriz E Rendon; Ming Zhao; Millicent Winner; Arlixer McGhee Coleman; Robert A Mitchell
Journal:  Mol Cancer Res       Date:  2010-11-11       Impact factor: 5.852

6.  HLA-DRα1 constructs block CD74 expression and MIF effects in experimental autoimmune encephalomyelitis.

Authors:  Roberto Meza-Romero; Gil Benedek; Xiaolin Yu; Jeffery L Mooney; Rony Dahan; Nerri Duvshani; Richard Bucala; Halina Offner; Yoram Reiter; Gregory G Burrows; Arthur A Vandenbark
Journal:  J Immunol       Date:  2014-03-28       Impact factor: 5.422

7.  Modeling of both shared and distinct interactions between MIF and its homologue D-DT with their common receptor CD74.

Authors:  Roberto Meza-Romero; Gil Benedek; Kelley Jordan; Lin Leng; Georgios Pantouris; Elias Lolis; Richard Bucala; Arthur A Vandenbark
Journal:  Cytokine       Date:  2016-08-27       Impact factor: 3.861

Review 8.  MIF family cytokines in cardiovascular diseases and prospects for precision-based therapeutics.

Authors:  Pathricia V Tilstam; Dake Qi; Lin Leng; Lawrence Young; Richard Bucala
Journal:  Expert Opin Ther Targets       Date:  2017-07       Impact factor: 6.902

9.  Modeling of eicosanoid fluxes reveals functional coupling between cyclooxygenases and terminal synthases.

Authors:  Yasuyuki Kihara; Shakti Gupta; Mano R Maurya; Aaron Armando; Ishita Shah; Oswald Quehenberger; Christopher K Glass; Edward A Dennis; Shankar Subramaniam
Journal:  Biophys J       Date:  2014-02-18       Impact factor: 4.033

10.  Involvement of macrophage migration inhibitory factor in cancer and novel therapeutic targets.

Authors:  Nadège Kindt; Fabrice Journe; Guy Laurent; Sven Saussez
Journal:  Oncol Lett       Date:  2016-08-02       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.